Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its Monte Carlo Dose Calculation algorithm has received 510(k) clearance from the U.S. Food and Drug Administration and is now commercially available worldwide. This announcement was made as part of the product's launch at the 9th Biennial European Society for Therapeutic Radiology and Oncology (ESTRO) meeting on Physics and Radiation Technology for Clinical Radiotherapy in Barcelona, Spain.
Accuray Receives FDA Clearance For New Dose Calculation Technique For Body Radiosurgery
0 comments :
Post a Comment